Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis
<p><strong>Objective</strong></p> This sequential, prospective meta-analysis (sPMA) sought to identify risk factors among pregnant and postpartum women with COVID-19 for adverse outcomes related to: disease severity, maternal morbidities, neonatal mortality and morbidity, adv...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2022
|
| _version_ | 1826309545533636608 |
|---|---|
| author | Smith, ER Oakley, E Grandner, GW Rukundo, G Farooq, F Ferguson, K Baumann, S Waldorf, KA Afshar, Y Ahlberg, M Ahmadzia, H Akelo, V Aldrovandi, G Bevilacqua, E Bracero, N Brandt, JS Broutet, N Carrillo, J Conry, J Cosmi, E Crispi, F Crovetto, F Gil, MDM Delgado-López, C Divakar, H Driscoll, AJ Favre, G Buhigas, IF Flaherman, V Gale, C Godwin, CL Gottlieb, S Gratacós, E He, S Hernandez, O Jones, S Joshi, S Kalafat, E Khagayi, S Knight, M Kotloff, K Lanzone, A Longo, VL Le Doare, K Lees, C Litman, E Lokken, EM Madhi, SA Magee, LA Martinez-Portilla, RJ |
| author_facet | Smith, ER Oakley, E Grandner, GW Rukundo, G Farooq, F Ferguson, K Baumann, S Waldorf, KA Afshar, Y Ahlberg, M Ahmadzia, H Akelo, V Aldrovandi, G Bevilacqua, E Bracero, N Brandt, JS Broutet, N Carrillo, J Conry, J Cosmi, E Crispi, F Crovetto, F Gil, MDM Delgado-López, C Divakar, H Driscoll, AJ Favre, G Buhigas, IF Flaherman, V Gale, C Godwin, CL Gottlieb, S Gratacós, E He, S Hernandez, O Jones, S Joshi, S Kalafat, E Khagayi, S Knight, M Kotloff, K Lanzone, A Longo, VL Le Doare, K Lees, C Litman, E Lokken, EM Madhi, SA Magee, LA Martinez-Portilla, RJ |
| author_sort | Smith, ER |
| collection | OXFORD |
| description | <p><strong>Objective</strong></p>
This sequential, prospective meta-analysis (sPMA) sought to identify risk factors among pregnant and postpartum women with COVID-19 for adverse outcomes related to: disease severity, maternal morbidities, neonatal mortality and morbidity, adverse birth outcomes.
<p><strong>Data sources</strong></p>
We prospectively invited study investigators to join the sPMA via professional research networks beginning in March 2020.
<p><strong>Study eligibility criteria</strong></p>
Eligible studies included those recruiting at least 25 consecutive cases of COVID-19 in pregnancy within a defined catchment area.
<p><strong>Study appraisal and synthesis methods</strong></p>
We included individual patient data from 21 participating studies. Data quality was assessed, and harmonized variables for risk factors and outcomes were constructed. Duplicate cases were removed. Pooled estimates for the absolute and relative risk of adverse outcomes comparing those with and without each risk factor were generated using a two-stage meta-analysis.
<p><strong>Results</strong></p>
We collected data from 33 countries and territories, including 21,977 cases of SARS-CoV-2 infection in pregnancy or postpartum. We found that women with comorbidities (pre-existing diabetes, hypertension, cardiovascular disease) versus those without were at higher risk for COVID-19 severity and pregnancy health outcomes (fetal death, preterm birth, low birthweight). Participants with COVID-19 and HIV were 1.74 times (95% CI: 1.12, 2.71) more likely to be admitted to the ICU. Pregnant women who were underweight before pregnancy were at higher risk of ICU admission (RR 5.53, 95% CI: 2.27, 13.44), ventilation (RR 9.36, 95% CI: 3.87, 22.63), and pregnancy-related death (RR 14.10, 95% CI: 2.83, 70.36). Pre-pregnancy obesity was also a risk factor for severe COVID-19 outcomes including ICU admission (RR 1.81, 95% CI: 1.26,2.60), ventilation (RR 2.05, 95% CI: 1.20,3.51), any critical care (RR 1.89, 95% CI: 1.28,2.77), and pneumonia (RR 1.66, 95% CI: 1.18,2.33). Anemic pregnant women with COVID-19 also had increased risk of ICU admission (RR 1.63, 95% CI: 1.25, 2.11) and death (RR 2.36, 95% CI: 1.15, 4.81).
<p><strong>Conclusion</strong></p>
We found that pregnant women with comorbidities including diabetes, hypertension, and cardiovascular disease were at increased risk for severe COVID-19-related outcomes, maternal morbidities, and adverse birth outcomes. We also identified several less commonly-known risk factors, including HIV infection, pre-pregnancy underweight, and anemia. Although pregnant women are already considered a high-risk population, special priority for prevention and treatment should be given to pregnant women with these additional risk factors. |
| first_indexed | 2024-03-07T07:37:20Z |
| format | Journal article |
| id | oxford-uuid:087477d6-8ac9-4156-87e9-571be1b344bc |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:37:20Z |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:087477d6-8ac9-4156-87e9-571be1b344bc2023-03-28T10:23:56ZClinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:087477d6-8ac9-4156-87e9-571be1b344bcEnglishSymplectic ElementsElsevier2022Smith, EROakley, EGrandner, GWRukundo, GFarooq, FFerguson, KBaumann, SWaldorf, KAAfshar, YAhlberg, MAhmadzia, HAkelo, VAldrovandi, GBevilacqua, EBracero, NBrandt, JSBroutet, NCarrillo, JConry, JCosmi, ECrispi, FCrovetto, FGil, MDMDelgado-López, CDivakar, HDriscoll, AJFavre, GBuhigas, IFFlaherman, VGale, CGodwin, CLGottlieb, SGratacós, EHe, SHernandez, OJones, SJoshi, SKalafat, EKhagayi, SKnight, MKotloff, KLanzone, ALongo, VLLe Doare, KLees, CLitman, ELokken, EMMadhi, SAMagee, LAMartinez-Portilla, RJ<p><strong>Objective</strong></p> This sequential, prospective meta-analysis (sPMA) sought to identify risk factors among pregnant and postpartum women with COVID-19 for adverse outcomes related to: disease severity, maternal morbidities, neonatal mortality and morbidity, adverse birth outcomes. <p><strong>Data sources</strong></p> We prospectively invited study investigators to join the sPMA via professional research networks beginning in March 2020. <p><strong>Study eligibility criteria</strong></p> Eligible studies included those recruiting at least 25 consecutive cases of COVID-19 in pregnancy within a defined catchment area. <p><strong>Study appraisal and synthesis methods</strong></p> We included individual patient data from 21 participating studies. Data quality was assessed, and harmonized variables for risk factors and outcomes were constructed. Duplicate cases were removed. Pooled estimates for the absolute and relative risk of adverse outcomes comparing those with and without each risk factor were generated using a two-stage meta-analysis. <p><strong>Results</strong></p> We collected data from 33 countries and territories, including 21,977 cases of SARS-CoV-2 infection in pregnancy or postpartum. We found that women with comorbidities (pre-existing diabetes, hypertension, cardiovascular disease) versus those without were at higher risk for COVID-19 severity and pregnancy health outcomes (fetal death, preterm birth, low birthweight). Participants with COVID-19 and HIV were 1.74 times (95% CI: 1.12, 2.71) more likely to be admitted to the ICU. Pregnant women who were underweight before pregnancy were at higher risk of ICU admission (RR 5.53, 95% CI: 2.27, 13.44), ventilation (RR 9.36, 95% CI: 3.87, 22.63), and pregnancy-related death (RR 14.10, 95% CI: 2.83, 70.36). Pre-pregnancy obesity was also a risk factor for severe COVID-19 outcomes including ICU admission (RR 1.81, 95% CI: 1.26,2.60), ventilation (RR 2.05, 95% CI: 1.20,3.51), any critical care (RR 1.89, 95% CI: 1.28,2.77), and pneumonia (RR 1.66, 95% CI: 1.18,2.33). Anemic pregnant women with COVID-19 also had increased risk of ICU admission (RR 1.63, 95% CI: 1.25, 2.11) and death (RR 2.36, 95% CI: 1.15, 4.81). <p><strong>Conclusion</strong></p> We found that pregnant women with comorbidities including diabetes, hypertension, and cardiovascular disease were at increased risk for severe COVID-19-related outcomes, maternal morbidities, and adverse birth outcomes. We also identified several less commonly-known risk factors, including HIV infection, pre-pregnancy underweight, and anemia. Although pregnant women are already considered a high-risk population, special priority for prevention and treatment should be given to pregnant women with these additional risk factors. |
| spellingShingle | Smith, ER Oakley, E Grandner, GW Rukundo, G Farooq, F Ferguson, K Baumann, S Waldorf, KA Afshar, Y Ahlberg, M Ahmadzia, H Akelo, V Aldrovandi, G Bevilacqua, E Bracero, N Brandt, JS Broutet, N Carrillo, J Conry, J Cosmi, E Crispi, F Crovetto, F Gil, MDM Delgado-López, C Divakar, H Driscoll, AJ Favre, G Buhigas, IF Flaherman, V Gale, C Godwin, CL Gottlieb, S Gratacós, E He, S Hernandez, O Jones, S Joshi, S Kalafat, E Khagayi, S Knight, M Kotloff, K Lanzone, A Longo, VL Le Doare, K Lees, C Litman, E Lokken, EM Madhi, SA Magee, LA Martinez-Portilla, RJ Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis |
| title | Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis |
| title_full | Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis |
| title_fullStr | Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis |
| title_full_unstemmed | Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis |
| title_short | Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis |
| title_sort | clinical risk factors of adverse outcomes among women with covid 19 in the pregnancy and postpartum period a sequential prospective meta analysis |
| work_keys_str_mv | AT smither clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT oakleye clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT grandnergw clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT rukundog clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT farooqf clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT fergusonk clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT baumanns clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT waldorfka clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT afshary clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT ahlbergm clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT ahmadziah clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT akelov clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT aldrovandig clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT bevilacquae clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT braceron clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT brandtjs clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT broutetn clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT carrilloj clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT conryj clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT cosmie clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT crispif clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT crovettof clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT gilmdm clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT delgadolopezc clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT divakarh clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT driscollaj clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT favreg clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT buhigasif clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT flahermanv clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT galec clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT godwincl clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT gottliebs clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT gratacose clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT hes clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT hernandezo clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT joness clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT joshis clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT kalafate clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT khagayis clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT knightm clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT kotloffk clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT lanzonea clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT longovl clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT ledoarek clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT leesc clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT litmane clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT lokkenem clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT madhisa clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT mageela clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis AT martinezportillarj clinicalriskfactorsofadverseoutcomesamongwomenwithcovid19inthepregnancyandpostpartumperiodasequentialprospectivemetaanalysis |